Support Grows for Proposed Ban on Retroactive DIR Fees
As reported this week by the National Community Pharmacists Association (NCPA), TPA and 98 other pharmacy stakeholders recently wrote the sponsors and original co-sponsors of S. 3308/H.R. 5951, the Improving Transparency and Accuracy in Medicare Part D Spending Act, which is aimed at reining in retroactive direct and indirect remuneration (DIR) fees imposed by pharmacy benefit managers (PBMs) in Medicare Part D. In our letter, we thanked the sponsors and co-sponsors for their leadership in introducing and endorsing this measure.
Two weeks ago, TPA asked members to contact their U.S. legislators to ask them to support this measure (and others). At that time, no Tennessee Representatives were co-sponsoring the House version of this bill. However, as a result of your efforts, two of them – Rep. Chuck Fleishmann and Rep. David Roe – have now signed on. We thank them for their support, and we thank YOU for your efforts! Let’s keep up the good work! Read on for information about this legislation, and find out how you can help.
Direct and Indirect Remuneration (DIR) Legislation
Please engage with your U.S. legislators regarding this important legislation! TPA has made it easier than ever to engage through the TPA website, using the automated Tennessee Pharmacists Legislative Action Network (T-PLAN) service!
How YOU Can Engage Through T-PLAN:
If you have questions about the Direct and Indirect Remuneration (DIR) Legislationabove, other legislative measures important to pharmacy, or how to use T-PLAN to contact your legislators, please don’t hesitate to reach out to me or a member of our TPA staff. If you’d like to learn more about how you can support pharmacy through advocacy, please visit the TPA Legislative Advocacy Center, and also consider becoming a contributor to the Tennessee Pharmacists Political Action Committee (PharmPAC).
Micah Cost, PharmD, MS
TPA Executive Director